Barclays BCS shares have soared 68.4% so far this year, outperforming the industry’s growth of 45.5%. Moreover, the company ...

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is one of the most promising stocks with huge upside potential. On November 24, ...

‘Hubs’ bring key market themes into focus, delivering cross-asset expert opinions, Signature reports, events and data - all in one streamlined location. From Deepseek to Tariffs 2.0, Hubs illuminate ...

NEW YORK--(BUSINESS WIRE)--Barclays Bank PLC (“Barclays”) announced today that it will exercise its issuer call option and redeem in full each of the 4 series of iPath ® ETNs (the “ETNs”) listed in ...

Barclays’ stock (NYSE: BCS) has gained 38% YTD, as compared to the 11% rise in the S&P500 over the same period. In comparison, Barclays’ peer Deutsche Bank (NYSE: DB) has seen its stock rise 24% over ...

Barclays reported a solid third quarter, with a continuation of positive trends for net interest income and operating expenses. Upgraded guidance for Barclays UK net interest income provides ...

Barclays Plc has a strong pipeline of deals across its investment and private-banking businesses in Africa as cross-border ...

Barclays PLC closed 0.22% below its 52-week high of £4.31, which the company achieved on November 13th.